Physician profile
Fernando Sosa
NPI 1760461099
$3,694.44
in general payments reported to CMS, 2019-2025
18 companies · $2,366 in 2025
The $2,366 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $140 · 2021: $364 · 2022: $176 · 2023: $239 · 2024: $287 · 2025: $2,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,675 · Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,675.09 |
| Food and Beverage | $1,216.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,773.83 | 2023-2025 | Mitraclip, Absolute Pro |
| Sobi, INC | $254.62 | 2021-2022 | |
| Glaxosmithkline, LLC. | $242.45 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $240.54 | 2019-2024 | |
| Philips North America LLC | $195.43 | 2025 | Igt Devices Undivided |
| Boston Scientific Corporation | $141.25 | 2025 | General - Therapies |
| Corium, LLC | $124.85 | 2022-2025 | Azstarys |
| Recor Medical INC | $118.47 | 2025 | Paradise Ultrasound Renal Denervation System |
| Merck Sharp & Dohme LLC | $106.11 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $105.75 | 2019-2024 | |
| Cardiva Medical, INC. | $101.44 | 2024 | Savvywire |
| Ironshore Pharmaceuticals INC. | $72.53 | 2019-2020 | |
| Tris Pharma INC | $58.16 | 2019-2021 | |
| Abiomed | $45.82 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.04 | 2020-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $25.48 | 2024 | Inspire |
| Acadia Pharmaceuticals INC | $23.99 | 2025 | Daybue |
| Phadia US INC. | $19.68 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Sosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.